Dissemin
Language
العربيّة
Deutsch
English
Español
Suomi
Français
한국어
Македонски
Português
Português Brasileiro
Русский
Svenska
Türkçe
简体中文
繁體中文
Login
Dissemin
Shanu Modi
Shah et al., 2015
Links
ORCID
Tools
Export citation
×
Format
BibTeX
@misc{Shah2015, author = {Shah, P. D. and Moynahan, M. E. and Modi, S. and Caravella, B. A. and Datko, F. M. and Zamora, S. and Comen, E. and Gilewski, T. and Sugarman, S. M. and D'Andrea, G. and Lake, D. E. and Goldfarb, S. B. and Patil, S. and Covey, A. and Berger, M. F. and Lacouture, M. E. and Norton, L. and Hudis, C. A. and Baselga, J. and Chandarlapaty, S. and Dickler, M. N.}, month = {may}, title = {Phase I trial: PI3K alpha inhibitor BYL719 plus aromatase inhibitor (AI) for patients with hormone receptor-positive (HR plus ) metastatic breast cancer (MBC)}, year = {2015} }
Export citation
Search in Google Scholar
Phase I trial: PI3K alpha inhibitor BYL719 plus aromatase inhibitor (AI) for patients with hormone receptor-positive (HR plus ) metastatic breast cancer (MBC)
Published in 2015 by
P. D. Shah
,
M. E. Moynahan
,
S. Modi
,
B. A. Caravella
,
F. M. Datko
,
S. Zamora
,
E. Comen
,
T. Gilewski
,
S. M. Sugarman
,
G. D'Andrea
,
D. E. Lake
,
S. B. Goldfarb
,
S. Patil
,
A. Covey
,
M. F. Berger
and
other authors.
P. D. Shah
,
M. E. Moynahan
,
S. Modi
,
B. A. Caravella
,
F. M. Datko
,
S. Zamora
,
E. Comen
,
T. Gilewski
,
S. M. Sugarman
,
G. D'Andrea
,
D. E. Lake
,
S. B. Goldfarb
,
S. Patil
,
A. Covey
,
M. F. Berger
,
M. E. Lacouture
,
L. Norton
,
C. A. Hudis
,
J. Baselga
,
S. Chandarlapaty
,
M. N. Dickler
Show less
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text:
Unavailable
Preprint
: policy unknown
Upload
Postprint
: policy unknown
Upload
Published version
: policy unknown
Upload